Underreported: Mefloquine use at Guantanamo

The Leonard Lopate Show | Jan 5, 2011

Detainees held by the United States government at the Guantanamo Bay prison have been administered very high doses of the drug Mefloquine, according to a new report from Seton Hall Law School. While the drug is a powerful anti-malarial, it also has a number of adverse side effects, which include hallucinations, paranoia and depression. On today’s Underreported segment Mark Denbeaux, one of the reports authors and director of the Seton Hall Law Center for Policy & Research, discusses why administration of the drug to detainees (at five times the regular dosage) is controversial.

WNYC is funded by sponsors and member donations

Top Stories

The World Cup, the Knicks, and LeBron James’s Fate: An All-Time Summer in Sports

The staff writer Louisa Thomas on the U.S. men’s national soccer team, the N.B.A. off-season, and Serena Williams.
The New Yorker Radio Hour |

The near-collapsed Midtown building is now stable, but its finances may not be

Experts say the structural failure at the Pfizer Building could cause financial problems and a lingering stigma — but that the city’s housing shortage means renters will probably move in anyway.
Gothamist |

NYC DSA on Their Big Wins, and the Future

NYC-DSA co-chairs Grace Mausser and Gustavo Gordillo talk about the DSA's recent big wins.
The Brian Lehrer Show |

Get Lit: Laila Lalami's 'The Dream Hotel,' and Imal Gnawa Performs

All Of It with Alison Stewart |
YOU ARE ONLINE